Moosmann, Peter <br/><br/>
Weekly treatment with a combination of bortezomib and bendamustine in relapsed or refractory indolent non-Hodgkin lymphoma.  [electronic resource] 

 -  Leukemia & lymphoma  Jan 2010 
 - 149-52 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Letter 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.3109/10428190903275602  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bendamustine Hydrochloride<br/>Boronic Acids--administration & dosage<br/>Bortezomib<br/>Cohort Studies<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Middle Aged<br/>Nitrogen Mustard Compounds--administration & dosage<br/>Protease Inhibitors--administration & dosage<br/>Pyrazines--administration & dosage<br/>Recurrence<br/>Treatment Outcome